CeCors Valuation
| CEOS Stock | USD 0.03 0 11.85% |
CeCors seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CeCors Inc from reviewing the firm fundamentals such as return on asset of -1.8, and Total Debt of 956.88 K as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CeCors' price fluctuation is out of control at this time. Calculation of the real value of CeCors Inc is based on 3 months time horizon. Increasing CeCors' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CeCors pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CeCors Inc. Since CeCors is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CeCors Pink Sheet. However, CeCors' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.029 | Real 0.0228 | Hype 0.03 | Naive 0.0296 |
The intrinsic value of CeCors' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CeCors' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CeCors Inc helps investors to forecast how CeCors pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CeCors more accurately as focusing exclusively on CeCors' fundamentals will not take into account other important factors: CeCors Total Value Analysis
CeCors Inc is currently estimated to have valuation of 87.7 K with market capitalization of 14.15 K, debt of 956.88 K, and cash on hands of 57.42 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CeCors fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.7 K | 14.15 K | 956.88 K | 57.42 K |
CeCors Asset Utilization
One of the ways to look at asset utilization of CeCors is to check how much profit was generated for every dollar of assets it reports. CeCors Inc owns a negative utilization of current and long term assets of -1.8 %, losing $0.018 for each dollar of current and long term assets held by the firm. Inadequate asset utilization signifies that the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of CeCors Inc shows how discouraging it operates for each dollar spent on its current and long term assets.CeCors Profitability Analysis
Net Loss for the year was (9.3 M) with profit before overhead, payroll, taxes, and interest of 0.About CeCors Valuation
The pink sheet valuation mechanism determines CeCors' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CeCors Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CeCors. We calculate exposure to CeCors's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CeCors's related companies.Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people.
8 Steps to conduct CeCors' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CeCors' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CeCors' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CeCors' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CeCors' revenue streams: Identify CeCors' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CeCors' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CeCors' growth potential: Evaluate CeCors' management, business model, and growth potential.
- Determine CeCors' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CeCors' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CeCors Growth Indicators
Investing in growth stocks can be very risky. If the company such as CeCors does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -30.2 M |
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.